Houston: A 53-year-old Indian-origin neurosurgeon in the US was fined over USD 2 million for medicare fraud after falsely ...

India's pharmaceutical market is projected to double to $120 billion by 2030, fueled by government initiatives and ...

A new handbook helps families care for head injury patients at home. The Neurological Society of India created the guide. It ...

The study highlights significant advancements by healthcare leaders in adopting new models of care to overcome staffing gaps, ...

A 53-year-old Indian-origin neurosurgeon in the US was fined over $2 million after falsely claiming to perform surgeries ...

Over the next five years, nearly 70% of global pharmaceuticals companies are expected to achieve annual growth exceeding 10% ...

Indian registry confirms mechanical thrombectomy for stroke is cost-effective, with excellent outcomes, but underutilized due ...

The India-based trial, the first of its kind, confirmed that systolic BP levels decreased no matter the exact mix of three ...

India’s climate tech growth opens doors for entrepreneurs and investors to drive sustainability. Already the world’s ...

A 53-year-old Indian-origin neurosurgeon in the US was fined over USD 2 million for medicare fraud after falsely claiming to perform surgeries to implant electro-acupuncture devices. Dr Rajesh Bindal ...

Developed by Mumbai-based Wockhardt, it will be available under brand name Miqnaf. Administering it once-a-day for 3 days ...

In 2023, Dr Reddy's signed a licensing and commercialisation agreement with Shanghai Junshi Biosciences for Toripalimab ...